PharmaSGP Holding SE
XETRA:PSG

Watchlist Manager

PharmaSGP Holding SE

XETRA:PSG

Watchlist

Dividends

Discount Rate

Price: 25.2 EUR

Market Cap: 302.2m EUR

Have any thoughts about
PharmaSGP Holding SE?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Estee Lauder Companies Inc NYSE:EL	Consumer products
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Church & Dwight Co Inc NYSE:CHD	Consumer products
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	American Express Co NYSE:AXP	Financial Services
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Target Corp NYSE:TGT	Retail
US	Walt Disney Co NYSE:DIS	Media
US	Mueller Industries Inc NYSE:MLI	Machinery
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 25.2 EUR

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

PSG Alert

PharmaSGP Holding SE

25.2

0.0 (0%)

52 Week Range	18.1 26
Price Target

We'll email you a reminder when the closing price reaches EUR.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Estee Lauder Companies Inc NYSE:EL	US
	Exxon Mobil Corp NYSE:XOM	US
	Church & Dwight Co Inc NYSE:CHD	US
	Pfizer Inc NYSE:PFE	US
	American Express Co NYSE:AXP	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Target Corp NYSE:TGT	US
	Walt Disney Co NYSE:DIS	US
	Mueller Industries Inc NYSE:MLI	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

PharmaSGP Holding SE

What unique competitive advantages
does PharmaSGP Holding SE hold over its rivals?

What risks and challenges
does PharmaSGP Holding SE face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of PharmaSGP Holding SE.

What unique competitive advantages
does PharmaSGP Holding SE hold over its rivals?

What risks and challenges
does PharmaSGP Holding SE face in the near future?

Has there been any significant insider trading activity
in PharmaSGP Holding SE recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for PharmaSGP Holding SE.

Provide P/S
for PharmaSGP Holding SE.

Provide P/E
for PharmaSGP Holding SE.

Provide P/OCF
for PharmaSGP Holding SE.

Provide P/FCFE
for PharmaSGP Holding SE.

Provide P/B
for PharmaSGP Holding SE.

Provide EV/S
for PharmaSGP Holding SE.

Provide EV/GP
for PharmaSGP Holding SE.

Provide EV/EBITDA
for PharmaSGP Holding SE.

Provide EV/EBIT
for PharmaSGP Holding SE.

Provide EV/OCF
for PharmaSGP Holding SE.

Provide EV/FCFF
for PharmaSGP Holding SE.

Provide EV/IC
for PharmaSGP Holding SE.

Show me price targets
for PharmaSGP Holding SE made by professional analysts.

What are the Revenue projections
for PharmaSGP Holding SE?

How accurate were the past Revenue estimates
for PharmaSGP Holding SE?

What are the Net Income projections
for PharmaSGP Holding SE?

How accurate were the past Net Income estimates
for PharmaSGP Holding SE?

What are the EPS projections
for PharmaSGP Holding SE?

How accurate were the past EPS estimates
for PharmaSGP Holding SE?

What are the EBIT projections
for PharmaSGP Holding SE?

How accurate were the past EBIT estimates
for PharmaSGP Holding SE?

Compare the revenue forecasts
for PharmaSGP Holding SE with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of PharmaSGP Holding SE and its key competitors using the latest financial data.

Compare historical revenue growth rates
of PharmaSGP Holding SE against its competitors.

Analyze the profit margins
(gross, operating, and net) of PharmaSGP Holding SE compared to its peers.

Compare the P/E ratios
of PharmaSGP Holding SE against its peers.

Discuss the investment returns and shareholder value creation
comparing PharmaSGP Holding SE with its peers.

Analyze the financial leverage
of PharmaSGP Holding SE compared to its main competitors.

Show all profitability ratios
for PharmaSGP Holding SE.

Provide ROE
for PharmaSGP Holding SE.

Provide ROA
for PharmaSGP Holding SE.

Provide ROIC
for PharmaSGP Holding SE.

Provide ROCE
for PharmaSGP Holding SE.

Provide Gross Margin
for PharmaSGP Holding SE.

Provide Operating Margin
for PharmaSGP Holding SE.

Provide Net Margin
for PharmaSGP Holding SE.

Provide FCF Margin
for PharmaSGP Holding SE.

Show all solvency ratios
for PharmaSGP Holding SE.

Provide D/E Ratio
for PharmaSGP Holding SE.

Provide D/A Ratio
for PharmaSGP Holding SE.

Provide Interest Coverage Ratio
for PharmaSGP Holding SE.

Provide Altman Z-Score Ratio
for PharmaSGP Holding SE.

Provide Quick Ratio
for PharmaSGP Holding SE.

Provide Current Ratio
for PharmaSGP Holding SE.

Provide Cash Ratio
for PharmaSGP Holding SE.

What is the historical Revenue growth
over the last 5 years for PharmaSGP Holding SE?

What is the historical Net Income growth
over the last 5 years for PharmaSGP Holding SE?

What is the current Free Cash Flow
of PharmaSGP Holding SE?

Discuss the annual earnings per share (EPS)
trend over the past five years for PharmaSGP Holding SE.

P/E
Price to Earnings

16.6

Current

24.5

Median

Industry

Lower than median

Lower than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E

16.6

Market Cap

302.2m EUR

Net Income

18.2m EUR

All Countries

Forward Multiples

			Market Cap	P/E
DE		PharmaSGP Holding SE XETRA:PSG	302.2m EUR	16.6
JP	N	Nichi-Iko Pharmaceutical Co Ltd TSE:4541	776 550.9T JPY	-5 347 888.9
US		Eli Lilly and Co NYSE:LLY	746.8B USD	89.2
UK		Dechra Pharmaceuticals PLC LSE:DPH	440.4B GBP	-15 783.5
DK		Novo Nordisk A/S CSE:NOVO B	3.3T DKK	34.4
US		Johnson & Johnson NYSE:JNJ	365.6B USD	24.9
US		Merck & Co Inc NYSE:MRK	249.1B USD	20.5
CH		Roche Holding AG SIX:ROG	202.9B CHF	17.7
CH		Novartis AG SIX:NOVN	179.4B CHF	12.5
UK		AstraZeneca PLC LSE:AZN	155.5B GBP	30.6
IE	E	Endo International PLC LSE:0Y5F	146B USD	-49.9

				Earnings Growth
DE		PharmaSGP Holding SE XETRA:PSG	Average P/E: 30.8 16.6	59%
JP	N	Nichi-Iko Pharmaceutical Co Ltd TSE:4541	Negative Multiple: -5 347 888.9	N/A
US		Eli Lilly and Co NYSE:LLY	89.2	451%
UK		Dechra Pharmaceuticals PLC LSE:DPH	Negative Multiple: -15 783.5	N/A
DK		Novo Nordisk A/S CSE:NOVO B	34.4	86%
US		Johnson & Johnson NYSE:JNJ	24.9	-22%
US		Merck & Co Inc NYSE:MRK	20.5	7 336%
CH		Roche Holding AG SIX:ROG	17.7	32%
CH		Novartis AG SIX:NOVN	12.5	21%
UK		AstraZeneca PLC LSE:AZN	30.6	177%
IE	E	Endo International PLC LSE:0Y5F	Negative Multiple: -49.9	N/A

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

P/E

15.7

2-Years Forward

P/E

13.3

3-Years Forward

P/E

11.6

PharmaSGP Holding SE
XETRA:PSG

P/E
Price to Earnings

P/E Forward Multiples

See Also

Company

Help

Tools

Stocks

PharmaSGP Holding SE XETRA:PSG

P/E Price to Earnings

P/E Forward Multiples

See Also

Company

Help

Tools

Stocks

PharmaSGP Holding SE
XETRA:PSG

P/E
Price to Earnings